We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical Company (EMN - Free Report) is benefiting from cost-cutting and productivity actions as well as its innovation-driven growth model amid challenges from soft demand in certain markets.
Eastman Chemical, which is among the prominent players in the chemical space along with Dow Inc. (DOW - Free Report) , Celanese Corporation (CE - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) , is expected to benefit from lower operating costs from its operational transformation program in 2024.
EMN is taking action to keep its manufacturing and administrative costs in control. It achieved cost savings of around $200 million in 2023, net of inflation. Pricing initiatives and lower raw material and energy costs are also expected to support the company’s bottom line. The company plans to maintain pricing discipline and improve asset utilization throughout the year.
Moreover, Eastman's goal is to increase new business revenues by utilizing its innovation-driven growth strategy. Its sales volumes are expected to be supported by the innovation and market development initiatives.
The company is also expected to gain from the revenues and earnings generated by its Kingsport methanolysis facility in 2024. It anticipates a $50 million incremental EBITDA contribution from the Kingsport facility.
Eastman Chemical also remains focused on maintaining a disciplined approach to capital allocation with an emphasis on debt reduction. It returned $526 million to shareholders in 2023 through dividends and share repurchases. It also raised its dividend for the 14th consecutive year. EMN expects to repurchase shares worth around $300 million in 2024.
However, EMN is exposed to headwinds from weak demand in certain markets. It is seeing soft demand in building & construction and cautious customer behavior in consumer durables and electronics. Demand in building & construction remains sluggish in most regions. While Eastman Chemical is seeing an end of customer inventory de-stocking across most of its end markets, the same is expected to continue in medical applications in the second half of 2024. Weaker demand is expected to adversely impact its performance in the third quarter of 2024.
EMN, on its second-quarter call, said that it expects earnings per share for 2024 to be between $7.40 and $7.85. It also expects to deliver around $1.4 billion in operating cash flow in 2024.
Another prominent chemical maker, Dow is seeing growing demand in many markets that it serves. However, it does not expect a significant change in demand in building & construction and consumer durables in 2024. It will continue driving higher sales through its innovation portfolio and diverse product mix. DOW remains on track to deliver higher earnings and shareholder returns by leveraging its global scale, strategically advantaged cost positions and growth investments.
Celanese expects adjusted earnings in the range of $2.75-$3 per share for the third quarter of 2024. Furthermore, based on the impact of the second-quarter force majeure and ongoing demand issues, CE forecasts full-year adjusted earnings per share in the range of $10.25 to $10.75.
Air Products, on its fiscal third-quarter call, maintained its fiscal 2024 full-year adjusted earnings per share projection of $12.20 to $12.50, suggesting a 6-9% increase from the previous year. The company’s adjusted earnings per share guidance for the fiscal fourth quarter is $3.33-$3.63.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman (EMN) Gains on Cost Cuts & Innovation Amid Demand Woes
Eastman Chemical Company (EMN - Free Report) is benefiting from cost-cutting and productivity actions as well as its innovation-driven growth model amid challenges from soft demand in certain markets.
Eastman Chemical, which is among the prominent players in the chemical space along with Dow Inc. (DOW - Free Report) , Celanese Corporation (CE - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) , is expected to benefit from lower operating costs from its operational transformation program in 2024.
EMN is taking action to keep its manufacturing and administrative costs in control. It achieved cost savings of around $200 million in 2023, net of inflation. Pricing initiatives and lower raw material and energy costs are also expected to support the company’s bottom line. The company plans to maintain pricing discipline and improve asset utilization throughout the year.
Moreover, Eastman's goal is to increase new business revenues by utilizing its innovation-driven growth strategy. Its sales volumes are expected to be supported by the innovation and market development initiatives.
The company is also expected to gain from the revenues and earnings generated by its Kingsport methanolysis facility in 2024. It anticipates a $50 million incremental EBITDA contribution from the Kingsport facility.
Eastman Chemical also remains focused on maintaining a disciplined approach to capital allocation with an emphasis on debt reduction. It returned $526 million to shareholders in 2023 through dividends and share repurchases. It also raised its dividend for the 14th consecutive year. EMN expects to repurchase shares worth around $300 million in 2024.
However, EMN is exposed to headwinds from weak demand in certain markets. It is seeing soft demand in building & construction and cautious customer behavior in consumer durables and electronics. Demand in building & construction remains sluggish in most regions. While Eastman Chemical is seeing an end of customer inventory de-stocking across most of its end markets, the same is expected to continue in medical applications in the second half of 2024. Weaker demand is expected to adversely impact its performance in the third quarter of 2024.
EMN, on its second-quarter call, said that it expects earnings per share for 2024 to be between $7.40 and $7.85. It also expects to deliver around $1.4 billion in operating cash flow in 2024.
Another prominent chemical maker, Dow is seeing growing demand in many markets that it serves. However, it does not expect a significant change in demand in building & construction and consumer durables in 2024. It will continue driving higher sales through its innovation portfolio and diverse product mix. DOW remains on track to deliver higher earnings and shareholder returns by leveraging its global scale, strategically advantaged cost positions and growth investments.
Celanese expects adjusted earnings in the range of $2.75-$3 per share for the third quarter of 2024. Furthermore, based on the impact of the second-quarter force majeure and ongoing demand issues, CE forecasts full-year adjusted earnings per share in the range of $10.25 to $10.75.
Air Products, on its fiscal third-quarter call, maintained its fiscal 2024 full-year adjusted earnings per share projection of $12.20 to $12.50, suggesting a 6-9% increase from the previous year. The company’s adjusted earnings per share guidance for the fiscal fourth quarter is $3.33-$3.63.